CA Patent

CA2510625A1 — Crystalline forms of gatifloxacin and processes for preparation

Assigned to Individual · Expires 2004-07-01 · 22y expired

What this patent protects

Provided are novel crystalline forms of gatifloxacin, some of which are DMSO solvates, and methods for making them.

USPTO Abstract

Provided are novel crystalline forms of gatifloxacin, some of which are DMSO solvates, and methods for making them.

Drugs covered by this patent

vadadustat (VADADUSTAT)

Patent Metadata

Patent number: CA2510625A1
Jurisdiction: CA
Classification: —
Expires: 2004-07-01
Drug substance claim: No
Drug product claim: No
Assignee: Individual
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.